Be part of the knowledge.™

Oncology and Hematology

3162

LikeLikedUnlike

Recognizing High-Risk Profiles for NSCLC
Project Oncology®
Recognizing High-Risk Profiles for NSCLC
- Jobelle Baldonado, MD
  Peer
Oncogenic Drivers in Never-Smokers with NSCLC
Project Oncology®
Oncogenic Drivers in Never-Smokers with NSCLC
- Apar Kishor Ganti, MD, MS
  Peer
Expanding Molecular Testing in Community NSCLC Care
Project Oncology®
Expanding Molecular Testing in Community NSCLC Care
- Apar Kishor Ganti, MD, MS
  Peer
Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
Project Oncology®
Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
- Brian P. McDonough, MD, FAAFP
  Peer
- Tara Graff, DO, MS
  Peer
- Surbhi Sidana, MD
  Peer
Tracking Treatment Response: ctDNA Insights in MMR-p Colon Cancer
Project Oncology®
Tracking Treatment Response: ctDNA Insights in MMR-p Colon Cancer
- Brian P. McDonough, MD, FAAFP
  Peer
- Christopher T. Chen, MD
  Peer
Addressing Unmet Needs in First-Line mTNBC Care
On the Frontlines of Metastatic Breast Cancer
Addressing Unmet Needs in First-Line mTNBC Care
- Jennifer Caudle, DO, FACOFP
  Peer
- Alexis Ann LeVee, MD
  Peer
advertisement

Q-Challenge™
Advancing Prostate Cancer Care: Integrating Guideline Updates and Patient Prefe…
4 questions
Q-Challenge™
BTK-Based Approach for Managing CLL/SLL
3 questions
Q-Challenge™
Biomarker-Driven First-Line Therapy for Metastatic Gastric/GEJ Cancers
4 questions
Q-Challenge™
HER2-Targeted ADCs in Advanced NSCLC
2 questions
Q-Challenge™
Unresectable Hepatocellular Carcinoma: Selecting the Optimal First-Line ICI Com…
10 questions
Q-Challenge™
A Personalized Approach to Perioperative Immunotherapy in Early-Stage Resectabl…
4 questions
advertisement

Rewiring Your Thinking in Paroxysmal Nocturnal Hemoglobinuria
Medical Industry Feature
Rewiring Your Thinking in Paroxysmal Nocturnal Hemoglobinuria
- Steve Stone, PA-C
  Peer
- George Yaghmour, MD
  Peer
Moving Beyond Hesitation: Exploring an Oral Option for Managing PNH
Medical Industry Feature
Moving Beyond Hesitation: Exploring an Oral Option for Managing PNH
- Steve Stone, PA-C
  Peer
- Jamile Shammo, MD, FASCP, FACP
  Peer
Personalizing PNH Care: Exploring the Role of Iptacopan in Clinical Practice
Medical Industry Feature
Personalizing PNH Care: Exploring the Role of Iptacopan in Clinical Practice
- Steve Stone, PA-C
  Peer
- Srinivasa Sanikommu, MD
  Peer
Bridging the Gap in AYA Cure Rates
Medical Industry Feature
Bridging the Gap in AYA Cure Rates
- Ibrahim Aldoss, MD
  Peer
Harnessing the Immune Power: A Uniquely Designed PD-1 Inhibitor for Esophageal Cancer
Project Oncology®
Harnessing the Immune Power: A Uniquely Designed PD-1 Inhibitor for Esophageal Cancer
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Jaffer Ajani, MD
  Peer
Latest TROP2 ADC Approval for HR+ HER2- Metastatic Breast Cancer
Medical Industry Feature
Latest TROP2 ADC Approval for HR+ HER2- Metastatic Breast Cancer
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Komal Jhaveri, MD, FACP
  Peer
- Vanessa Soto-Romano
  Peer

Medical News
Rising cSCC and CIS Incidence in Denmark: Registry Findings (2005–2023)
02/19/2026
Medical News
FDA Approves Optune Pax for Locally Advanced Pancreatic Cancer
02/19/2026
Medical News
M-PACT: AI-Driven Methylation Liquid Biopsy for Pediatric CNS Tumor Classificat…
02/19/2026
Medical News
Dysplasia Grade and Colorectal Cancer risk in IBD: Cohort Summary
02/18/2026
Medical News
FDA Approves Once‑Monthly SC RYBREVANT FASPRO: Implications for Clinic Operatio…
02/18/2026
Medical News
Adaptive Molecular Subtyping in Treated Breast Cancer: Reporting Paired Tissue …
02/18/2026

Program Chapters

Segment Chapters

Playlist:

Recommended